SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7
- PMID: 27182967
- DOI: 10.1038/ng.3569
SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7
Abstract
Adrenal hypoplasia is a rare, life-threatening congenital disorder. Here we define a new form of syndromic adrenal hypoplasia, which we propose to term MIRAGE (myelodysplasia, infection, restriction of growth, adrenal hypoplasia, genital phenotypes, and enteropathy) syndrome. By exome sequencing and follow-up studies, we identified 11 patients with adrenal hypoplasia and common extra-adrenal features harboring mutations in SAMD9. Expression of the wild-type SAMD9 protein, a facilitator of endosome fusion, caused mild growth restriction in cultured cells, whereas expression of mutants caused profound growth inhibition. Patient-derived fibroblasts had restricted growth, decreased plasma membrane EGFR expression, increased size of early endosomes, and intracellular accumulation of giant vesicles carrying a late endosome marker. Of interest, two patients developed myelodysplasitc syndrome (MDS) that was accompanied by loss of the chromosome 7 carrying the SAMD9 mutation. Considering the potent growth-restricting activity of the SAMD9 mutants, the loss of chromosome 7 presumably occurred as an adaptation to the growth-restricting condition.
Similar articles
-
Emerging phenotypes linked to variants in SAMD9 and MIRAGE syndrome.Front Endocrinol (Lausanne). 2022 Aug 18;13:953707. doi: 10.3389/fendo.2022.953707. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36060959 Free PMC article.
-
Two patients with MIRAGE syndrome lacking haematological features: role of somatic second-site reversion SAMD9 mutations.J Med Genet. 2018 Feb;55(2):81-85. doi: 10.1136/jmedgenet-2017-105020. Epub 2017 Nov 24. J Med Genet. 2018. PMID: 29175836
-
A novel SAMD9 mutation causing MIRAGE syndrome: An expansion and review of phenotype, dysmorphology, and natural history.Am J Med Genet A. 2018 Feb;176(2):415-420. doi: 10.1002/ajmg.a.38557. Epub 2017 Dec 21. Am J Med Genet A. 2018. PMID: 29266745
-
A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases.Pediatr Blood Cancer. 2019 Jul;66(7):e27726. doi: 10.1002/pbc.27726. Epub 2019 Mar 21. Pediatr Blood Cancer. 2019. PMID: 30900330 Review.
-
SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.Leukemia. 2018 May;32(5):1106-1115. doi: 10.1038/s41375-018-0074-4. Epub 2018 Feb 25. Leukemia. 2018. PMID: 29535429 Free PMC article. Review.
Cited by
-
Neutropenia in the age of genetic testing: Advances and challenges.Am J Hematol. 2019 Mar;94(3):384-393. doi: 10.1002/ajh.25374. Epub 2019 Jan 8. Am J Hematol. 2019. PMID: 30536760 Free PMC article. Review.
-
Human Host Range Restriction of the Vaccinia Virus C7/K1 Double Deletion Mutant Is Mediated by an Atypical Mode of Translation Inhibition.J Virol. 2018 Nov 12;92(23):e01329-18. doi: 10.1128/JVI.01329-18. Print 2018 Dec 1. J Virol. 2018. PMID: 30209174 Free PMC article.
-
The Clinical Spectrum, Diagnosis, and Management of GATA2 Deficiency.Cancers (Basel). 2023 Mar 3;15(5):1590. doi: 10.3390/cancers15051590. Cancers (Basel). 2023. PMID: 36900380 Free PMC article. Review.
-
Acquired uniparental disomy of chromosome 7 in a patient with MIRAGE syndrome that veiled a pathogenic SAMD9 variant.Clin Pediatr Endocrinol. 2021;30(4):163-169. doi: 10.1297/cpe.30.163. Epub 2021 Oct 1. Clin Pediatr Endocrinol. 2021. PMID: 34629738 Free PMC article.
-
EAHP 2020 workshop proceedings, pediatric myeloid neoplasms.Virchows Arch. 2022 Oct;481(4):621-646. doi: 10.1007/s00428-022-03375-8. Epub 2022 Jul 11. Virchows Arch. 2022. PMID: 35819517 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous